Wednesday, July 29

Browsing: AZD3470

Survivors

AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma

By NewsCancerMay 30, 20260

Giving the PRMT5 inhibitor AZD3470 as monotherapy showed clinical activity among patients with classic Hodgkin lymphoma who relapsed or were…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.